These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 13120873)

  • 41. [Electronic structure and mode of action of folic acid antimetabolites].
    PERAULT AM; PULLMAN B
    Biochim Biophys Acta; 1961 Sep; 52():266-80. PubMed ID: 14485201
    [No Abstract]   [Full Text] [Related]  

  • 42. The activities of some 2 : 4-diaminopteridines and sulphathiazole against Streptococcus faecalis and Staphylococcus aureus.
    COLLIER HO; WATERHOUSE PD
    Br J Pharmacol Chemother; 1952 Mar; 7(1):161-9. PubMed ID: 14904914
    [No Abstract]   [Full Text] [Related]  

  • 43. Studies on the folic acid vitamins. III. The duration of the effects of the folic acid antagonists in man.
    CONDIT PT
    Cancer; 1960; 13():229-35. PubMed ID: 13811475
    [No Abstract]   [Full Text] [Related]  

  • 44. Diastereoisomers of formaldehyde derivatives of tetrahydrofolic acid and tetrahydroaminopterin.
    Horwitz SB; Kwok G; Wilson L; Kisliuk RL
    J Med Chem; 1969 Jan; 12(1):49-51. PubMed ID: 4883936
    [No Abstract]   [Full Text] [Related]  

  • 45. New mechanism for a classic folate inhibitor.
    Brown HA
    Nat Chem Biol; 2008 Oct; 4(10):581-2. PubMed ID: 18800042
    [No Abstract]   [Full Text] [Related]  

  • 46. Inhibition of thymidylate synthetase by the new quinazoline antifolate, CB 3717; enzyme purification and kinetics.
    Jackman AL; Calvert AH; Hart LI; Harrap KR
    Adv Exp Med Biol; 1984; 165 Pt B():375-8. PubMed ID: 6720434
    [No Abstract]   [Full Text] [Related]  

  • 47. Antimetabolites and antibiotics as tools for research on blood formation.
    JUKES TH
    Am J Clin Nutr; 1955; 3(1):56-63. PubMed ID: 14349903
    [No Abstract]   [Full Text] [Related]  

  • 48. 3D-QSAR Study on dihydro-1,3,5-triazines and their spiro derivatives as DHFR inhibitors by comparative molecular field analysis (CoMFA).
    Ma X; Xiang G; Yap CW; Chui WK
    Bioorg Med Chem Lett; 2012 May; 22(9):3194-7. PubMed ID: 22483391
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of bovine and rat liver dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(4-substituted-phenyl)-s-triazines.
    Hansch C; Dietrich SW; Fukunaga JY
    J Med Chem; 1981 May; 24(5):544-9. PubMed ID: 7241512
    [No Abstract]   [Full Text] [Related]  

  • 50. Novel folate-hydroxamate based antimetabolites: synthesis and biological evaluation.
    Carrasco MP; Enyedy EA; Krupenko NI; Krupenko SA; Nuti E; Tuccinardi T; Santamaria S; Rossello A; Martinelli A; Santos MA
    Med Chem; 2011 Jul; 7(4):265-74. PubMed ID: 21568878
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of the growth of an ame-thopterin-refractory tumor by dietary restriction of folic acid.
    ROSEN F; NICHOL CA
    Cancer Res; 1962 May; 22():495-500. PubMed ID: 14493889
    [No Abstract]   [Full Text] [Related]  

  • 52. Folate antagonists from a crude "X-methyl folate" preparation.
    Stokstad EL; Reisenauer A; Watson JE; Schlingmann G
    Biochem Biophys Res Commun; 1981 Nov; 103(2):447-53. PubMed ID: 6800363
    [No Abstract]   [Full Text] [Related]  

  • 53. [Antimetabolites of folic acid metabolism with chemotherapeutic activity against rodent malaria (Plasmodium vinckei)].
    Heischkeil R
    Z Tropenmed Parasitol; 1973 Dec; 24(4):505-16. PubMed ID: 4778588
    [No Abstract]   [Full Text] [Related]  

  • 54. The antifolates: evolution, new agents in the clinic, and how targeting delivery via specific membrane transporters is driving the development of a next generation of folate analogs.
    Goldman ID; Chattopadhyay S; Zhao R; Moran R
    Curr Opin Investig Drugs; 2010 Dec; 11(12):1409-23. PubMed ID: 21154123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The inhibition of dihydrofolate reductase by folate analogues: structural requirements for slow- and tight-binding inhibition.
    Williams JW; Duggleby RG; Cutler R; Morrison JF
    Biochem Pharmacol; 1980 Feb; 29(4):589-95. PubMed ID: 7370052
    [No Abstract]   [Full Text] [Related]  

  • 56. Antagonists of purine and pyrimidine metabolites and of folic acid.
    TIMMIS GM
    Adv Cancer Res; 1961; 6():369-401. PubMed ID: 13921293
    [No Abstract]   [Full Text] [Related]  

  • 57. A comparison of the inhibition of bovine and murine leukemia dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(3-X-phenyl)-s-triazines.
    Guo ZR; Dietrich SW; Hansch C; Dolnick BJ; Bertino JR
    Mol Pharmacol; 1981 Nov; 20(3):649-56. PubMed ID: 7329407
    [No Abstract]   [Full Text] [Related]  

  • 58. Studies on the nature of resistance of Streptococcus faecalis to folic acid antagonists.
    ANTON AH; NICHOL CA
    Biochem Pharmacol; 1959 Dec; 3():1-9. PubMed ID: 13793858
    [No Abstract]   [Full Text] [Related]  

  • 59. The mechanisms of action of antitumor compounds.
    Belousova AK
    Natl Cancer Inst Monogr; 1977 Mar; (45):183-93. PubMed ID: 73135
    [No Abstract]   [Full Text] [Related]  

  • 60. Design, synthesis and biological evaluation of 6-aryl-1,6-dihydro-1,3,5-triazine-2,4-diamines as antiplasmodial antifolates.
    Lourens AC; Gravestock D; van Zyl RL; Hoppe HC; Kolesnikova N; Taweechai S; Yuthavong Y; Kamchonwongpaisan S; Rousseau AL
    Org Biomol Chem; 2016 Aug; 14(33):7899-911. PubMed ID: 27477595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.